 |
The Journal of Neuroscience, April 21, 2004, 24(16):3899-3906; doi:10.1523/JNEUROSCI.0283-04.2004
Previous Article | Next Article 
Neurobiology of Disease
Age-Dependent Neurodegeneration and Alzheimer-Amyloid Plaque Formation in Transgenic Drosophila
Isabell Greeve,1,2
Doris Kretzschmar,3
Jakob-Andreas Tschäpe,3
Anika Beyn,1,5
Claire Brellinger,1
Michaela Schweizer,1
Roger M. Nitsch,1,4 and
Rita Reifegerste1,5
1Center for Molecular Neurobiology, University of Hamburg, 20251 Hamburg, Germany, 2Department of Neurology, Inselspital University Hospital Bern, 3010 Bern, Switzerland, 3Center for Research on Occupational and Environmental Toxicology, Oregon Health and Sciences University, Portland, Oregon 97201, 4Division of Psychiatry Research, University of Zurich, 8008 Zurich, Switzerland, and 5Evotec Neurosciences GmbH, 22525 Hamburg, Germany
-Amyloid peptides that are cleaved from the amyloid precursor protein (APP) play a critical role in Alzheimer's disease (AD) pathophysiology. Here, we show that in Drosophila, the targeted expression of the key genes of AD, APP, the -site APP-cleaving enzyme BACE, and the presenilins led to the generation of -amyloid plaques and age-dependent neurodegeneration as well as to semilethality, a shortened life span, and defects in wing vein development. Genetic manipulations or pharmacological treatments with secretase inhibitors influenced the activity of the APP-processing proteases and modulated the severity of the phenotypes. This invertebrate model of amyloid plaque pathology demonstrates A -induced neurodegeneration as a basic biological principle and may allow additional genetic analyses of the underlying molecular pathways.
Key words: Alzheimer; dementia; aging; neuropathology; degeneration; Drosophila
Received Jan 25, 2004;
revised March 7, 2004;
accepted March 8, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
A. Muhammad, I. Flores, H. Zhang, R. Yu, A. Staniszewski, E. Planel, M. Herman, L. Ho, R. Kreber, L. S. Honig, et al.
Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and A{beta} accumulation
PNAS,
May 20, 2008;
105(20):
7327 - 7332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rajendran, A. Schneider, G. Schlechtingen, S. Weidlich, J. Ries, T. Braxmeier, P. Schwille, J. B. Schulz, C. Schroeder, M. Simons, et al.
Efficient Inhibition of the Alzheimer's Disease {beta}-Secretase by Membrane Targeting
Science,
April 25, 2008;
320(5875):
520 - 523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Cao, H.-J. Song, T. Gangi, A. Kelkar, I. Antani, D. Garza, and M. Konsolaki
Identification of Novel Genes That Modify Phenotypes Induced by Alzheimer's {beta}-Amyloid Overexpression in Drosophila
Genetics,
March 1, 2008;
178(3):
1457 - 1471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Li, Z. Xie, Y. Dong, K. M. McKay, M. L. McKee, and R. E. Tanzi
Isolation and characterization of the Drosophila ubiquilin ortholog dUbqln: in vivo interaction with early-onset Alzheimer disease genes
Hum. Mol. Genet.,
November 1, 2007;
16(21):
2626 - 2639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Celotto and M. J. Palladino
Drosophila: A "Model" Model System To Study Neurodegeneration
Mol. Interv.,
October 1, 2005;
5(5):
292 - 303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Buckingham, B. Esmaeili, M. Wood, and D. B. Sattelle
RNA interference: from model organisms towards therapy for neural and neuromuscular disorders
Hum. Mol. Genet.,
October 1, 2004;
13(suppl_2):
R275 - R288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Banerjee, J. Lee, K. Venkatesh, C.-F. Wu, and G. Hasan
Loss of Flight and Associated Neuronal Rhythmicity in Inositol 1,4,5-Trisphosphate Receptor Mutants of Drosophila
J. Neurosci.,
September 8, 2004;
24(36):
7869 - 7878.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|